Results 171 to 180 of about 143,199,576 (301)
ABSTRACT Objective Multiple sclerosis (MS) is a neurodegenerative demyelinating disease of the central nervous system. This study aimed to identify micro‐RNA (miRNA)–mRNA regulatory networks underlying region‐specific molecular mechanisms in white matter and gray matter lesions in progressive MS.
Adya Sapra +5 more
wiley +1 more source
application/pdf; Includes bibliographical references (page [44 of 71]).A set of 9 Annual Reports from Subcommittees of the Governor's Behavioral Health Services Planning Council, and 1 summary.Aging Subcommittee Report 2013 (July 10, 2013).
Kansas. Governor's Behavioral Health Services Planning Council.
core
Analysis of the current situation and factors influencing the utilization of somatic and somatic-mental disorder comorbidity and health services among middle-aged and older adult people in China. [PDF]
Xue M, Zhang Q, Wu J, Tian K.
europepmc +1 more source
Vascular Disease, Non‐Steroidal Anti‐Inflammatory Drugs and Risk of Parkinson's Disease
ABSTRACT Objectives A history of vascular disease has been shown to be associated with an increased risk of Parkinson's disease, but this may be due to reverse causation. In addition, non‐steroidal anti‐inflammatory drugs are thought to reduce Parkinson's disease risk, but evidence is inconsistent and confounding by prior vascular disease is possible ...
Clare Wotton +4 more
wiley +1 more source
Factors associated with utilization of oral health services among adults aged 18-70 years in Lira district, Northern Uganda: a community based cross-sectional study. [PDF]
Ojok S +6 more
europepmc +1 more source
Progressive Parkinsonism in PPP2R5D‐Related Neurodevelopmental Disorder
ABSTRACT PPP2R5D‐related neurodevelopmental disorder (Houge–Janssens syndrome type 1) is a rare autosomal dominant condition characterized by macrocephaly, intellectual disability, and epilepsy. Progressive parkinsonism is an emerging adult phenotype that neurologists should be aware of since timely genetic diagnosis opens the door to disease‐modifying
Katerina Bernardi +6 more
wiley +1 more source
ABSTRACT Objective To determine whether discontinuing anti‐CD20 therapy in people with relapsing‐onset MS aged over 50 is associated with an increased risk of relapse, inflammatory activity, confirmed disability accrual, and serious infection compared with continuing therapy.
Alexia Moukhine +40 more
wiley +1 more source
Pharmaceutical policy has become one of the most important and hotly contested domains of health system management - a rise in prominence largely due to financial realities.
University of British Columbia. Centre for Health Services and Policy Research
core
Augmenting and Assaying Nav1.1 Protein Quantity for Dravet Syndrome Therapy
ABSTRACT Dravet Syndrome (DS) is a developmental and epileptic encephalopathy predominantly caused by heterozygous loss‐of‐function variants in SCN1A, which encodes Nav1.1. Conserved upstream open reading frames (uORFs) in SCN1A were validated to regulate translation in reporter assays, demonstrating the therapeutic viability of increasing Nav1.1 from ...
Aiswarya Saravanan +7 more
wiley +1 more source
"February 28, 2018."; Presentation before the Kansas Legislature, Senate Public Health and Welfare Committee, by KanCare, Kansas Department for Aging and Disability Services.Presentation describing the individual and shared duties of the Kansas ...
KanCare.
core

